762 related articles for article (PubMed ID: 28106744)
1. Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases.
Liao W; Dong J; Peh HY; Tan LH; Lim KS; Li L; Wong WF
Molecules; 2017 Jan; 22(1):. PubMed ID: 28106744
[TBL] [Abstract][Full Text] [Related]
2. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease.
Séguin RM; Ferrari N
Expert Opin Investig Drugs; 2009 Oct; 18(10):1505-17. PubMed ID: 19715448
[TBL] [Abstract][Full Text] [Related]
3. Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases.
Mehta M; Deeksha ; Tewari D; Gupta G; Awasthi R; Singh H; Pandey P; Chellappan DK; Wadhwa R; Collet T; Hansbro PM; Kumar SR; Thangavelu L; Negi P; Dua K; Satija S
Chem Biol Interact; 2019 Aug; 308():206-215. PubMed ID: 31136735
[TBL] [Abstract][Full Text] [Related]
4. The role of microRNAs in chronic respiratory disease: recent insights.
Stolzenburg LR; Harris A
Biol Chem; 2018 Feb; 399(3):219-234. PubMed ID: 29148977
[TBL] [Abstract][Full Text] [Related]
5. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
6. Respirable antisense oligonucleotides: a new, third drug class targeting respiratory disease.
Nyce J
Curr Opin Allergy Clin Immunol; 2002 Dec; 2(6):533-6. PubMed ID: 14752337
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic RNA Strategies for Chronic Obstructive Pulmonary Disease.
Mei D; Tan WSD; Tay Y; Mukhopadhyay A; Wong WSF
Trends Pharmacol Sci; 2020 Jul; 41(7):475-486. PubMed ID: 32434654
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological strategies to regain steroid sensitivity in severe asthma and COPD.
Mei D; Tan WSD; Wong WSF
Curr Opin Pharmacol; 2019 Jun; 46():73-81. PubMed ID: 31078066
[TBL] [Abstract][Full Text] [Related]
9. From Genesis to Revelation: The Role of Inflammatory Mediators in Chronic Respiratory Diseases and their Control by Nucleic Acid-based Drugs.
Gioia SD; Sardo C; Castellani S; Porsio B; Belgiovine G; Carbone A; Giammona G; Cavallaro G; Conese M
Curr Drug Deliv; 2017; 14(2):253-271. PubMed ID: 27557670
[TBL] [Abstract][Full Text] [Related]
10. [New therapeutic options in pulmonary diseases in 2016 : focus on asthma, COPD and idiopathic pulmonary fibrosis (IPF)].
Gianella P; Glatz N; Berra G; Janssens JP
Rev Med Suisse; 2017 Jan; 13(544-545):96-101. PubMed ID: 28703547
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic targets for novel therapies of lung diseases.
Comer BS; Ba M; Singer CA; Gerthoffer WT
Pharmacol Ther; 2015 Mar; 147():91-110. PubMed ID: 25448041
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer.
Takakura K; Kawamura A; Torisu Y; Koido S; Yahagi N; Saruta M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284594
[TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide-targeting periostin ameliorates pulmonary fibrosis.
Tomaru A; Kobayashi T; Hinneh JA; Baffour Tonto P; D'Alessandro-Gabazza CN; Fujimoto H; Fujiwara K; Takahashi Y; Ohnishi M; Yasuma T; Nishihama K; Yoshino M; Takao K; Toda M; Totoki T; Takei Y; Yoshikawa K; Taguchi O; Gabazza EC
Gene Ther; 2017 Nov; 24(11):706-716. PubMed ID: 28820502
[TBL] [Abstract][Full Text] [Related]
14. Use of biologics to treat acute exacerbations and manage disease in asthma, COPD and IPF.
Murray LA; Grainge C; Wark PA; Knight DA
Pharmacol Ther; 2017 Jan; 169():1-12. PubMed ID: 27889330
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation.
Sun Y; Zhao Y; Zhao X; Lee RJ; Teng L; Zhou C
Molecules; 2017 Oct; 22(10):. PubMed ID: 29027965
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotides: New therapeutic approaches for asthma and chronic obstructive pulmonary disease.
Parry-Billings M; Ferrari N; Seguin R
Curr Opin Investig Drugs; 2010 Nov; 11(11):1276-85. PubMed ID: 21157647
[TBL] [Abstract][Full Text] [Related]
17. Is there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies?
Joos GF; Gabazza EC
Respirology; 2015 Jan; 20(1):15-23. PubMed ID: 25410652
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic responses in asthma and COPD. Corticosteroids.
Larj MJ; Bleecker ER
Chest; 2004 Aug; 126(2 Suppl):138S-149S; discussion 159S-161S. PubMed ID: 15302774
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targets in lung tissue remodelling and fibrosis.
Liu G; Philp AM; Corte T; Travis MA; Schilter H; Hansbro NG; Burns CJ; Eapen MS; Sohal SS; Burgess JK; Hansbro PM
Pharmacol Ther; 2021 Sep; 225():107839. PubMed ID: 33774068
[TBL] [Abstract][Full Text] [Related]
20. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.
Nakawah MO; Hawkins C; Barbandi F
J Am Board Fam Med; 2013; 26(4):470-7. PubMed ID: 23833163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
